pharmaphorum

JULY 23, 2019

This pharmaphorum webinar, in association with Tag, will examine the challenges that pharma marketing faces to stay ahead of the evolving customer journey and offer expert insight from both the pharma and FMCG sectors on how to convert these challenges into opportunities.

Marketing 52

Marketing Production Development Research 52

pharmaphorum

DECEMBER 17, 2020

Kevin Morgan, head of product and process, Europe, at the social media firm, notes in a blog post that in January it introduced an in-app notice so that when users searched for hashtags related to the pandemic, they would be provided with easy links to the World Health Organisation’s website and the British Red Cross.

Scientist 96

Scientist Vaccination Vaccine Medicine 96

XTalks

AUGUST 19, 2022

Along with beti-cel, there is one being developed for sickle cell (approved in Europe as Skysona or eli-cel) and another being jointly developed with Bristol Myers Squibb for melanoma. Zynteglo’s hefty price tag of $2.8 Bluebird has a total of three gene therapies in its pipeline.

Gene Therapy 95

Gene Therapy FDA Approval Gene Clinical Trials 95

pharmaphorum

JANUARY 9, 2023

” Zolgensma is one of the most expensive therapies available, with a price tag of around $2.1 million in the US and just under €2 million in Europe, which the company says is justified by its dramatic benefits when given as a one-shot therapy to patients with SMA.

Gene Therapy 118

Gene Therapy Genetics Gene Clinical Trials 118

pharmaphorum

JUNE 12, 2022

Beti-cel has already been approved for marketing in Europe as Zynteglo, with a price tag of around $1.8 Eli-cel was also previously approved in Europe as Skysona. million price tag, saying its ability to help patients reach sustained transfusion independence justified its high price.

Gene Therapy 58

Gene Therapy Gene Marketing Trials 58

pharmaphorum

JANUARY 21, 2022

The Oslo Medicines Initiative (OMI), which held its first public webinar event last week, was conceived before the pandemic, but it has gained new relevance as it seeks to address this disparity in Europe, a union of countries with hugely varying income levels. WHO is OMI?

Medicine 52

Medicine Marketing Manufacturing Production 52

pharmaphorum

JANUARY 11, 2021

The gene therapy firm will be focused on its most important therapies in beta-thalassemia, cerebral adrenoleukodystrophy and sickle cell disease in the US And Europe. Zynteglo is already in beta-thalassemia in Europe, where the company will seek to expand access despite its hefty $1.8 million price tag.

Gene Therapy 60

Gene Therapy Gene Genetic Disease Manufacturing 60

XTalks

OCTOBER 26, 2021

The treatment came with an initial price tag of $39,000 per vial, which amounts to a total of $575,00 each year. AHP affects 1 in 100,000 people in Europe. An estimated 5,000 people experience one or more AHP attacks yearly in the US and Europe, and 1,000 have severe and frequent attacks.

Gene Silencing 98

Gene Silencing Gene Clinical Trials Clinical Trials 98

XTalks

JULY 16, 2021

But yet, the price tag is still higher than real meat. A pound of Beyond Meat’s Beef burgers carries a price tag of $6.25, Vox reported. Plant-based foods in China and Europe have adopted this approach with success. Turning a Profit. Wouldn’t the higher demand lower plant-based meat prices ? How to Lower Plant-Based Meat Prices.

Protein 105

Protein Production Manufacturing Branding 105

pharmaphorum

NOVEMBER 19, 2020

Because Roche has never applied for Avastin to be used in wet AMD, clinics in the US have had to choose between the peace of mind offered by the regulatory process and Lucentis’ higher price tag, or the unapproved off-label formulation of Avastin at a lower price.

FDA Approval 63

FDA Approval Marketing Drugs Clinical Development 63

pharmaphorum

FEBRUARY 22, 2021

Last week, Bluebird said it was pausing its Zynteglo (betibeglogene autotemcel) programme in Europe after a phase 1/2 trial in patients with sickle cell disease (SCD) – another red blood cell disorder – turned up two cases of blood cancers, one of acute myeloid leukaemia (AML) and another of myelodysplastic syndrome (MDS). million in Europe.

Gene Therapy 52

Gene Therapy Gene Gene Sequencing Gene Expression 52

pharmaphorum

AUGUST 18, 2022

The US approval comes three years after Zynteglo (betibeglogene autotemcel) was approved for the same indication in Europe, and subsequently withdrawn after bluebird concluded that it wasn’t possible to build a commercially viable business for the gene therapy as the pricing and reimbursement environment there was too “hostile.”

Gene Therapy 52

Gene Therapy FDA Approval Gene Clinical Trials 52

pharmaphorum

JUNE 2, 2022

And of course, in many cases, these drugs have higher than average price tags compared to the wider market which is due to the limited – or in most cases – non-existent competition within a treatment area.”. However, the spokesperson for Evaluate does not see any sign of immediate action in Europe in the area of orphan drugs.

Drugs 52

Drugs Sales Marketing Development 52

XTalks

SEPTEMBER 27, 2022

The record-breaking price tag of Skysona is not surprising for one-time gene therapies like it. Case in point, bluebird had to pull both Zynteglo and Skysona and cease commercial activities in Europe after it failed to reach reimbursement agreements with local governments. Related: Bluebird’s $2.8M

FDA Approval 52

FDA Approval Gene Therapy Drugs Gene 52

pharmaphorum

MAY 17, 2021

Apellis’ drug is also under review in Europe, with a decision anticipated sometime before the end of this year. In that study, patients in the Empaveli group saw an average increase of 2.4 g/dL in haemoglobin levels, while those in the Soliris arm had an average decrease of 1.5 billion and $1.1

Drugs 52

Drugs FDA Approval Marketing Clinical Trials 52

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Development 52

Development Drugs Clinical Development Antibody 52

pharmaphorum

AUGUST 26, 2022

BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe. The post Roctavian okay sets up another gene therapy test for Europe appeared first on. million spread over five years.

Gene Therapy 110

Gene Therapy Gene Antibody Marketing 110

pharmaphorum

NOVEMBER 16, 2022

However, with a price tag of €1.58 However, a recently released report from the organisation could blow the price tag of Zolgensma out of the water. When even high-income regions like Europe are refusing to meet the price tag of certain gene therapies, it is likely the debate on pricing is set to continue in the long-term.

Gene Therapy 131

Gene Therapy Gene Marketing Development 131

Delveinsight

DECEMBER 3, 2020

The FDA nods for the Elecsys Anti-SARS-CoV-2 S quantitative antibody test that runs on Roche’s cobas e analyzers, follows its September launch in Europe after receiving a CE mark. of the time and negative results 99.98% of the time, as per Roche. Merck chooses TriNKET cancer immunotherapy program.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

pharmaphorum

DECEMBER 2, 2020

AZ seemed to have little interest in the idea, and the deal was instantly controversial in both Europe and the US. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag. In 2014 the company made an offer of around $100 billion to acquire UK firm AstraZeneca (which at the time was going through a rough patch ).

Sales 128

Sales Production Drugs Marketing 128

pharmaphorum

NOVEMBER 19, 2021

Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. billion, with more than $500 million coming from Europe and $455 million from emerging markets. However, Europe has decided not to renew AZ’s contract next year, preferring to focus on the slightly more efficacious mRNA jabs. per dose in the US and €19.50

Sales 137

Sales Vaccination Vaccine Marketing 137

pharmaphorum

MARCH 27, 2022

Both CAR-Ts are directed at BCMA, a biomarker for multiple myeloma also targeted by GlaxoSmithKline’s approved antibody-drug conjugate Blenrep (belantamab mafodotin) and J&J’s experimental bispecific antibody teclistamab, which was submitted for approval in Europe last month.

Antibody 97

Antibody Clinical Trials Clinical Trials Sales 97

pharmaphorum

FEBRUARY 16, 2021

In this first draft guidance NICE raised a series of issues with Zynteglo, which bluebird has already agreed to supply at a confidential discount from its hefty price tag, which is around €1.57 million in Europe. NICE said that data came from a small sample of patients and is using its standard discount rate of 3.5%

Gene Therapy 80

Gene Therapy Gene Medicine Development 80

Pharmaceutical Technology

JANUARY 27, 2023

cases per million in Europe. Over the last few years, as price tags for drugs have continuously increased, the popularity of risk sharing agreements has been increasing at a rate of 24% annual average growth. The disorder has a reported annual incidence between 1.5

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

Drug Discovery World

NOVEMBER 13, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Yuchih Lin, Doctor, Sino Biological Europe, on: ‘Accelerating drug discovery using advanced antibody development platforms’.

Protein 59

Protein Antibody Engineer Scientist 59

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Iain Moal, PhD, Scientific Leader, Computational Antibody Engineering, GSK, on: ‘Learning antibody binding affinity using FACS and NGS’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

XTalks

AUGUST 17, 2020

The core framework of the Immuno-STAT molecule consists of: HLA peptide – specifically HLA-A*02, which is the most dominant HLA allele in North America and Western Europe. The study commenced in September 2019 (NCT03978689) and interim data is expected later this year.

Protein 98

Protein Engineer Immune Response In-Vivo 98

Cloudbyz

JUNE 1, 2023

Here are some key points about Salesforce’s global data centers: Geographical Spread: Salesforce’s data centers are strategically spread across various regions around the world, including North America, Europe, and Asia. They also adhere to local data protection and privacy laws, such as GDPR in Europe.

Compliance 87

Compliance Development Branding Production 87

pharmaphorum

FEBRUARY 26, 2021

In 1959, J&J acquired McNeil Laboratories in the US and also Cilag Chemie, AG in Europe. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. Following World War II, Ethicon’s market share in surgical sutures rose from 15% to 70% worldwide.

Sales 126

Sales Production Pharma Companies Marketing 126

The Pharma Data

MAY 4, 2021

and developed Europe following the approvals in 2019 for combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced renal cell carcinoma; as well as. First-quarter 2021 operational growth was primarily driven by: BNT162b2, which contributed $3.5 in December 2019; and. Source link.

Vaccination 40

Vaccination Vaccine Production Sales 40